BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34649968)

  • 1. Identification of a recurrent mosaic
    Green TE; MacGregor D; Carden SM; Harris RV; Hewitt CA; Berkovic SF; Penington AJ; Scheffer IE; Hildebrand MS
    Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34649968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
    Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
    Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
    J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.
    Kapoor S; Scanga HL; Reyes-Múgica M; Nischal KK
    Am J Med Genet A; 2021 Dec; 185(12):3825-3830. PubMed ID: 34254724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report.
    Pan C; Zhou X; Hong A; Fang F; Wang Y
    BMC Med Genomics; 2020 Dec; 13(1):188. PubMed ID: 33308209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
    Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
    Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Patient With Schimmelpenning Syndrome and Mosaic KRAS Mutation.
    Mitchell BJ; Rogers GF; Wood BC
    J Craniofac Surg; 2019 Jan; 30(1):184-185. PubMed ID: 30394973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant.
    Wang H; Qian Y; Wu B; Zhang P; Zhou W
    BMC Med Genet; 2015 Oct; 16():101. PubMed ID: 26521233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
    Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
    Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of KRAS Mutations in Cortical Malformation and Epilepsy Surgery: A Novel Report of Nevus Sebaceous Syndrome and Review of the Literature.
    Pepi C; de Palma L; Trivisano M; Pietrafusa N; Lepri FR; Diociaiuti A; Camassei FD; Carfi-Pavia G; De Benedictis A; Rossi-Espagnet C; Vigevano F; Marras CE; Novelli A; Bluemcke I; Specchio N
    Brain Sci; 2021 Jun; 11(6):. PubMed ID: 34208656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRAS-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
    Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
    Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus.
    Minowa T; Kamiya T; Hida T; Okura M; Kato J; Idogawa M; Tange S; Hirano T; Tokino T; Uhara H
    J Dermatol; 2021 Aug; 48(8):1268-1272. PubMed ID: 33908086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversibility and developmental neuropathology of linear nevus sebaceous syndrome caused by dysregulation of the RAS pathway.
    Kim YE; Kim YS; Lee HE; So KH; Choe Y; Suh BC; Kim JH; Park SK; Mathern GW; Gleeson JG; Rah JC; Baek ST
    Cell Rep; 2023 Jan; 42(1):112003. PubMed ID: 36641749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
    Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
    J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sebaceous nevus of Jadassohn: review and clinical-surgical approach.
    Neto MPDS; Assis BR; Andrade GR
    An Bras Dermatol; 2022; 97(5):628-636. PubMed ID: 35863943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Schimmelpenning Syndrome Associated with Intracranial Tumors? A Case Report.
    Chiang MC; McDowell MM; Weaver K; Broniscer A; Greene S
    Pediatr Neurosurg; 2019; 54(3):201-206. PubMed ID: 30879010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
    Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
    J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
    Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
    J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
    Huang L; Zhang J; Chen F; Zhang X; Cao Y; Cheng R; Deng D
    J Dermatol; 2022 Sep; 49(9):921-924. PubMed ID: 35567308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inguinal lymph nodes agenesia in a patient with Schimmelpenning-Feuerstein-Mims syndrome with proven somatic KRAS mutation.
    Blanco Portals C; Gómez Tellado M; Del Pozo Losada J; Rodríguez Ruiz M
    Clin Exp Dermatol; 2022 Jan; 47(1):235-239. PubMed ID: 34435383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.